Experiencing additional difficulty in developing a common concept for galectin-3 levels in IBD, another study documented similar serum galectin-3 concentrations in IBD patients and healthy controls [147] (Table 1). This evidence concerns the gene LGALS3 and inflammatory bowel disease.